Does Marketing Have Too Much Control In Big Pharma Clinical Trials? - Forbes

Does Marketing Have Too Much Control In Big Pharma Clinical Trials? - Forbes | marketing - Google News | January 26, 2016 at 10:05AM

Forbes

Does Marketing Have Too Much Control In Big Pharma Clinical Trials? Forbes The title of this recent article really says it all: “Characterisation of trials where marketing purposes have been influential in study design: a descriptive study.” The authors' entering hypothesis essentially is that many of Big Pharma's clinical ...

January 26, 2016 at 10:05AM | marketing - Google News
Does Marketing Have Too Much Control In Big Pharma Clinical Trials? - Forbes
marketing - Google News